Effect of heparin administration on urine protein excretion during the developmental stage of experimentally induced laminitis in horses

Benjamin UbertiDepartments of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University West Lafayette, IN 47907

Search for other papers by Benjamin Uberti in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
Barrak M. PresslerDepartments of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University West Lafayette, IN 47907

Search for other papers by Barrak M. Pressler in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Stéphane B. AlkabesDepartments of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University West Lafayette, IN 47907

Search for other papers by Stéphane B. Alkabes in
Current site
Google Scholar
PubMed
Close
 DVM
,
Ching-Yun ChangComparative Pathobiology, School of Veterinary Medicine, Purdue University West Lafayette, IN 47907

Search for other papers by Ching-Yun Chang in
Current site
Google Scholar
PubMed
Close
 MS
,
George E. MooreComparative Pathobiology, School of Veterinary Medicine, Purdue University West Lafayette, IN 47907

Search for other papers by George E. Moore in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Timothy B. LescunDepartments of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University West Lafayette, IN 47907

Search for other papers by Timothy B. Lescun in
Current site
Google Scholar
PubMed
Close
 BVSc, MS
, and
Janice E. SojkaDepartments of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University West Lafayette, IN 47907

Search for other papers by Janice E. Sojka in
Current site
Google Scholar
PubMed
Close
 VMD, MS
View More View Less

Abstract

Objective—To investigate the effects of heparin administration on urine protein excretion during the developmental stages of experimentally induced laminitis in horses.

Animals—13 horses.

Procedures—Horses received unfractionated heparin (80 U/kg, SC, q 8 h; n = 7) or no treatment (control group; 6) beginning 3 days prior to induction of laminitis. All horses were given 3 oligofructose loading doses (1 g/kg each) at 24-hour intervals and a laminitis induction dose (10 g of oligofructose/kg) 24 hours following the final loading dose (designated as 0 hours) via nasogastric tube. Serum glucose and insulin concentrations were measured before administration of the first loading dose (baseline) and at 0 and 24 hours; urine protein-to-creatinine (UP:C) ratio was determined at 0 hours and every 4 hours thereafter. Lameness was evaluated every 6 hours, and horses were euthanized when Obel grade 2 ameness was observed.

Results—Mean ± SD time until euthanasia did not differ significantly between the heparin-treated (28.9 ± 6.5 hours) and control (29.0 ± 6.9 hours) horses. The UP:C ratio was significantly increased from baseline at 20 to 28 hours after induction of laminitis (ie, 4 ± 4 hours before lameness was evident) in control horses but did not change significantly from baseline in heparin-treated horses. Serum glucose or insulin concentration did not change significantly from baseline in either group.

Conclusions and Clinical Relevance—Urine protein excretion increased during the developmental stages of carbohydrate-induced laminitis in horses; administration of heparin prevented that increase, but did not delay onset or decrease severity of lameness.

Abstract

Objective—To investigate the effects of heparin administration on urine protein excretion during the developmental stages of experimentally induced laminitis in horses.

Animals—13 horses.

Procedures—Horses received unfractionated heparin (80 U/kg, SC, q 8 h; n = 7) or no treatment (control group; 6) beginning 3 days prior to induction of laminitis. All horses were given 3 oligofructose loading doses (1 g/kg each) at 24-hour intervals and a laminitis induction dose (10 g of oligofructose/kg) 24 hours following the final loading dose (designated as 0 hours) via nasogastric tube. Serum glucose and insulin concentrations were measured before administration of the first loading dose (baseline) and at 0 and 24 hours; urine protein-to-creatinine (UP:C) ratio was determined at 0 hours and every 4 hours thereafter. Lameness was evaluated every 6 hours, and horses were euthanized when Obel grade 2 ameness was observed.

Results—Mean ± SD time until euthanasia did not differ significantly between the heparin-treated (28.9 ± 6.5 hours) and control (29.0 ± 6.9 hours) horses. The UP:C ratio was significantly increased from baseline at 20 to 28 hours after induction of laminitis (ie, 4 ± 4 hours before lameness was evident) in control horses but did not change significantly from baseline in heparin-treated horses. Serum glucose or insulin concentration did not change significantly from baseline in either group.

Conclusions and Clinical Relevance—Urine protein excretion increased during the developmental stages of carbohydrate-induced laminitis in horses; administration of heparin prevented that increase, but did not delay onset or decrease severity of lameness.

Contributor Notes

Dr. Uberti's present address is Martin Y Omar 959, San Isidro (CP 1642), Buenos Aires, Argentina.

Supported by Indiana Racing Commission Funds.

Presented as a poster at the 22nd Phi Zeta Research Day, Purdue University School of Veterinary Medicine, West Lafayette, Ind, April 2009.

Address correspondence to Dr. Uberti (buberti@gmail.com).
  • 1

    Eades SC, Holm AMS, Moore RM. A review of the pathophysiology and treatment of acute laminitis: pathophysiologic and therapeutic implications of endothelin-1, in Proceedings. 48th Annu Conv Am Assoc Equine Pract 2002;353361.

    • Search Google Scholar
    • Export Citation
  • 2

    Moore RM, Eades SC, Stokes AM. Evidence for vascular and enzymatic events in the pathophysiology of acute laminitis: which pathway is responsible for initiation of this process in horses? Equine Vet J 2004; 36:204209.

    • Search Google Scholar
    • Export Citation
  • 3

    Johnson PJ, Messer NT, Ganjam VK. Cushing's syndromes, insulin resistance and endocrinopathic laminitis. Equine Vet J 2004; 36:194198.

  • 4

    van Eps AW, Pollitt CC. Equine laminitis induced with oligofructose. Equine Vet J 2006; 38:203208.

  • 5

    Bailey SR, Marr CM & Elliott J. Current research and theories on the pathogenesis of acute laminitis in the horse. Vet J 2004; 167:129142.

    • Search Google Scholar
    • Export Citation
  • 6

    Asplin KE, Sillence MN, Pollitt CC, et al. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet J 2007; 174:530535.

    • Search Google Scholar
    • Export Citation
  • 7

    Frank N. Endocrinopathic laminitis, obesity-associated laminitis, and pasture-associated laminitis, in Proceedings. 54th Annu Conv Am Assoc Equine Pract 2008; 54:341346.

    • Search Google Scholar
    • Export Citation
  • 8

    Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and non-diabetic individuals. JAMA 2001; 286:421426.

    • Search Google Scholar
    • Export Citation
  • 9

    Lees GE, Brown SA, Elliott J, et al. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM Forum consensus statement (small animal). J Vet Intern Med 2005; 19:377385.

    • Search Google Scholar
    • Export Citation
  • 10

    Uberti B, Eberle DB, Pressler BM, et al. Determination of and correlation between urine protein excretion and urine protein-to-creatinine ratio values during a 24-hour period in healthy horses and ponies. Am J Vet Res 2009; 70:15511556.

    • Search Google Scholar
    • Export Citation
  • 11

    Belknap JK, Moore JN. Evaluation of heparin for prophylaxis of equine laminitis: 71 cases (1980–1986). J Am Vet Med Assoc 1989; 195:505507.

    • Search Google Scholar
    • Export Citation
  • 12

    Moore BR, Hinchcliff KW. Heparin: a review of its pharmacology and therapeutic use in horses. J Vet Intern Med 1994; 8:2635.

  • 13

    Baldus S, Rudolph V, Roiss M, et al. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 2006; 113:18711878.

    • Search Google Scholar
    • Export Citation
  • 14

    de la Rebiere G, Franck T, Deby-Dupont G, et al. Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis. Vet J 2008; 178:6269.

    • Search Google Scholar
    • Export Citation
  • 15

    Deepa PR & Varalakshmi P. The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity. Eur J Pharmacol 2003; 478:199205.

    • Search Google Scholar
    • Export Citation
  • 16

    Miller MA, Pardo ID, Jackson LP, et al. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction. Vet Pathol 2008; 45:2638.

    • Search Google Scholar
    • Export Citation
  • 17

    Garner HE, Hutcheson DP, Coffman JR, et al. Lactic acidosis: a factor associated with equine laminitis. J Anim Sci 1977; 45:10371041.

  • 18

    Milinovich GJ, Trott DJ, Burrell PC, et al. Changes in equine hindgut bacterial populations during oligofructose-induced laminitis. Environ Microbiol 2006; 8:885898.

    • Search Google Scholar
    • Export Citation
  • 19

    Hood DM. Laminitis as a systemic disease. Vet Clin North Am Equine Pract 1999; 15:481494.

  • 20

    Bailey SR. The pathogenesis of acute laminitis: fitting more pieces into the puzzle. Equine Vet J 2004; 36:199203.

  • 21

    Nourian AR, Baldwin GI, van Eps AW, et al. Equine laminitis: ultrastructural lesions detected 24–30 hours after induction with oligofructose. Equine Vet J 2007; 39:360364.

    • Search Google Scholar
    • Export Citation
  • 22

    Neville RF, Hollands T, Collins SN, et al. Evaluation of urinary TBARS in normal and chronic laminitic ponies. Equine Vet J 2004; 36:292294.

    • Search Google Scholar
    • Export Citation
  • 23

    de Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int 2004; 66:21092118.

    • Search Google Scholar
    • Export Citation
  • 24

    Whittemore JC, Gill VL, Jensen WA, et al. Evaluation of the association between microalbuminuria and the urine albumin-creatinine ratio and systemic disease in dogs. J Am Vet Med Assoc 2006; 229:958963.

    • Search Google Scholar
    • Export Citation
  • 25

    Remuzzi G & Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339:14481456.

  • 26

    Wijnhoven TJ, Lensen JF, Rops AL, et al. Anti-proteinuric effects of glycosaminoglycan-based drugs. Curr Opin Mol Ther 2007; 9:364377.

  • 27

    Chen S, Wassenhove-McCarthy DJ, Yamaguchi Y, et al. Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int 2008; 74:289299.

    • Search Google Scholar
    • Export Citation
  • 28

    Guo Y, Wang Z, Dong L, et al. Ability of low-molecular-weight heparin to alleviate proteinuria by inhibiting respiratory syncytial virus infection. Nephrology (Carlton) 2008; 13:545553.

    • Search Google Scholar
    • Export Citation
  • 29

    Benck U, Haeckel S, Clorius JH, et al. Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system. Clin J Am Soc Nephrol 2007; 2:5867.

    • Search Google Scholar
    • Export Citation
  • 30

    Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337:688698.

  • 31

    Feige K, Schwarzwald CC & Bombeli T. Comparison of unfractioned and low molecular weight heparin for prophylaxis of coagulopathies in 52 horses with colic: a randomised double-blind clinical trial. Equine Vet J 2003; 35:506513.

    • Search Google Scholar
    • Export Citation
  • 32

    Wardle EN. How does hyperglycaemia predispose to diabetic nephropathy? QJM 1996; 89:943951.

  • 33

    Pratt SE, Geor RJ, McCutcheon LJ. Repeatability of 2 methods for assessment of insulin sensitivity and glucose dynamics in horses. J Vet Intern Med 2005; 19:883888.

    • Search Google Scholar
    • Export Citation
  • 34

    Treiber KH, Kronfeld DS, Hess TM, et al. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am J Vet Res 2005; 66:21142121.

    • Search Google Scholar
    • Export Citation

Advertisement